The MuSt-PC: A Multidimensional Strategy to improve quality of life of patients with multiple symptoms and Palliative Care needs Pilot study to assess the MuSt-PC tool

The MuSt-PC: A Multidimensional Strategy to improve quality of life of patients with multiple symptoms and Palliative Care needs Pilot study to assess the MuSt-PC tool - The MuSt-PC: a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53744

Enrollment

Registered

2023-05-12

Start date

2024-04-18

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patiënten met kanker, hartfalen, COPD. All diseases: cancer heart failure or COPD

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients identified as in a palliative care trajectory (based on a negative answer to the surprise question *Would I be surprised if this patient died in the next 12 months?*) • All diseases: cancer, heart failure or COPD • Patients should have pain and at least one other symptom on the Utrecht Symptom Diary with a numeric rating score of 4 or higher • Life expectancy of at least 4 weeks • Able to fill out Dutch questionnaires • Informed consent

Exclusion criteria

Exclusion criteria: • Patients who are unable or unwilling to self-assess their symptoms at baseline.

Design outcomes

Primary

Measure	Time frame
The primary objective is to assess the ability and willingness of patients to complete follow-up assessments (i.e. the number of patients who completed all questionnaires during follow-up). After a baseline assessment, all patients will be asked to fill out the Utrecht Symptom Diary during two weeks. In the first week, twice daily (morning and evening), in the second week once daily (evening).	—

Secondary

Measure	Time frame
• Recruitment of patients; the number of patients that consented and those that declined participation (with the reason of decline), as well as number of eligible patients (with at least two items on USD-4D >= 4 at baseline) (% of patients); • Adherence to advice by patients (medical (e.g., intake of medication) and non-medical (e.g.,relaxation exercises) provided based on the MuSt-PC CDSS (%); • Patient impressions of the MuSt-PC CDSS (10 questions with a 4-point Likert scale); • Time until symptom burden decreases after the use of the MuSt-PC CDSS based on the filled out Utrecht Symptom Diaries (days); • Feedback about the follow-up assessments within this pilot (open questions).	—

Measure

Time frame

• Recruitment of patients; the number of patients that consented and those that declined participation (with the reason of decline), as well as number of eligible patients (with at least two items on USD-4D >= 4 at baseline) (% of patients); • Adherence to advice by patients (medical (e.g., intake of medication) and non-medical (e.g.,relaxation exercises) provided based on the MuSt-PC CDSS (%); • Patient impressions of the MuSt-PC CDSS (10 questions with a 4-point Likert scale); • Time until symptom burden decreases after the use of the MuSt-PC CDSS based on the filled out Utrecht Symptom Diaries (days); • Feedback about the follow-up assessments within this pilot (open questions).

—

Countries

Netherlands

Outcome results